Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Investing > RECORD YEAR SEES PHARMA MARKETING SPECIALIST ATTRACT INVESTMENT
    Investing

    RECORD YEAR SEES PHARMA MARKETING SPECIALIST ATTRACT INVESTMENT

    Published by Gbaf News

    Posted on October 7, 2017

    5 min read

    Last updated: January 21, 2026

    The Quantoz Payments logo highlights the company's announcement of Mark de Bos as Head of Finance, emphasizing his extensive experience in finance and compliance within the banking sector.
    Quantoz Payments logo representing the appointment of Mark de Bos as Head of Finance - Global Banking & Finance Review

    PHARMACEUTICAL and biotech outsourcing expert ramarketing is eyeing up a US base after attracting backing from a high profile pharmaceutical business figure.

    The six-figure investment from industry expert Fiona Cruickshank OBE who founded The Specials Laboratory follows a record year for the digital, marketing and PR business that has seen it grow by 70% and double staff numbers to over 20.

    Having operated in the contract services sector for many years, ramarketing works with some of the most high-profile names in the sector including Recipharm, Eurofins and TraceLink to help raise their profile, generate leads and ultimately grow their business. Its global client-base also includes many specialist players such as Symbiosis, Juniper Pharma Services, Tjoapack and Quanticate.

    Fiona said: “I am very pleased to be investing in a strong team whose track record, approach and knowledge of the outsourcing space makes it so successful.  Export sales now account for around 40% of the business, and there is real potential to increase that even further with a US presence.”

    Founded in 2009 by sector specialist Raman Sehgal, the UK-headquartered agency specialises in design, digital and PR services for companies operating across the outsourcing sector, including those involved in research and development, manufacturing, packaging and technology.

    Raman said: “This has been a record 12 months for the business, averaging out at over 50% year on year growth since 2014.  Our roots are in the North East of England like many pharmaceutical companies, but our long-term aim has always been to establish ourselves as a specialist, international agency, which is where I believe we are now.

    “Our disruptive, agile and results-driven approach has led to us to become one of the biggest creative agency players in the contract services space in Europe, so we are now actively looking for an office on the East coast of the USA. With clients all over the world, it makes sense to look at creating new bases where we see potential for growth and can service clients locally.

    “The US market is certainly competitive but we feel we have the edge over many others due to our knowledge of the European market, which is ideal for companies looking to expand presence in Europe. Likewise, we are already running PR, digital and lead generation campaigns in the US for our European-based clients so having boots on the ground will bring huge added value.”

    The company’s team is representing over 20 companies at the upcoming CPhI Worldwide in Frankfurt, supporting with stand design, media meetings and marketing campaigns.

    PHARMACEUTICAL and biotech outsourcing expert ramarketing is eyeing up a US base after attracting backing from a high profile pharmaceutical business figure.

    The six-figure investment from industry expert Fiona Cruickshank OBE who founded The Specials Laboratory follows a record year for the digital, marketing and PR business that has seen it grow by 70% and double staff numbers to over 20.

    Having operated in the contract services sector for many years, ramarketing works with some of the most high-profile names in the sector including Recipharm, Eurofins and TraceLink to help raise their profile, generate leads and ultimately grow their business. Its global client-base also includes many specialist players such as Symbiosis, Juniper Pharma Services, Tjoapack and Quanticate.

    Fiona said: “I am very pleased to be investing in a strong team whose track record, approach and knowledge of the outsourcing space makes it so successful.  Export sales now account for around 40% of the business, and there is real potential to increase that even further with a US presence.”

    Founded in 2009 by sector specialist Raman Sehgal, the UK-headquartered agency specialises in design, digital and PR services for companies operating across the outsourcing sector, including those involved in research and development, manufacturing, packaging and technology.

    Raman said: “This has been a record 12 months for the business, averaging out at over 50% year on year growth since 2014.  Our roots are in the North East of England like many pharmaceutical companies, but our long-term aim has always been to establish ourselves as a specialist, international agency, which is where I believe we are now.

    “Our disruptive, agile and results-driven approach has led to us to become one of the biggest creative agency players in the contract services space in Europe, so we are now actively looking for an office on the East coast of the USA. With clients all over the world, it makes sense to look at creating new bases where we see potential for growth and can service clients locally.

    “The US market is certainly competitive but we feel we have the edge over many others due to our knowledge of the European market, which is ideal for companies looking to expand presence in Europe. Likewise, we are already running PR, digital and lead generation campaigns in the US for our European-based clients so having boots on the ground will bring huge added value.”

    The company’s team is representing over 20 companies at the upcoming CPhI Worldwide in Frankfurt, supporting with stand design, media meetings and marketing campaigns.

    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Investing

    Explore more articles in the Investing category

    Image for Understanding the Factors Shaping Bitcoin’s Current Market Conditions
    Understanding the Factors Shaping Bitcoin’s Current Market Conditions
    Image for Understanding Investment Management Consulting Services in the U.S. Market
    Understanding Investment Management Consulting Services in the U.S. Market
    Image for The Role of DST Sponsors and Service Providers in Delaware Statutory Trusts
    The Role of DST Sponsors and Service Providers in Delaware Statutory Trusts
    Image for Understanding Self-Directed IRA Structures and Platform Models
    Understanding Self-Directed IRA Structures and Platform Models
    Image for 1031 Exchanges and Delaware Statutory Trusts: What Investors Need to Know
    1031 Exchanges and Delaware Statutory Trusts: What Investors Need to Know
    Image for Excellence in Innovation – Strategic Investment & Economic Transformation Egypt 2025
    Excellence in Innovation – Strategic Investment & Economic Transformation Egypt 2025
    Image for What Is the Average Pension Pot in the UK? (By Age)
    What Is the Average Pension Pot in the UK? (By Age)
    Image for From Money Printing to Market Surge: The Macro Forces Driving Crypto in 2026
    From Money Printing to Market Surge: The Macro Forces Driving Crypto in 2026
    Image for  Millennials Aren’t Ignoring Retirement. They’re Rebuilding It.
    Millennials Aren’t Ignoring Retirement. They’re Rebuilding It.
    Image for BridgeWise Launches FixedWise, the First AI Solution Bringing Granular Bond Intelligence to the European Market
    BridgeWise Launches FixedWise, the First AI Solution Bringing Granular Bond Intelligence to the European Market
    Image for Why Financial Advisors Are Rethinking Gold Allocations
    Why Financial Advisors Are Rethinking Gold Allocations
    Image for From Opaque to Investable: Yaniv Bertele's Blueprint for Transparent Alternatives
    From Opaque to Investable: Yaniv Bertele's Blueprint for Transparent Alternatives
    View All Investing Posts
    Previous Investing PostMITON’S ANTHONY RAYNER: BETTER THE DEVIL YOU KNOW?
    Next Investing PostHONESTY MATTERS TO INVESTORS